Respiratory device market was valued at $25,909.1 million in 2025 and is projected to reach $49,914.2 million by 2035, growing at a CAGR of 6.3% during the forecast period (2026-2035). Pivotal factors which are driving the demand for this market includes growth in chronic diseases, ageing population, preference for home based care and technological advancements. However, chronic diseases remains the strongest factor which is accelerating the demand for respiratory devices market.
Browse the full report description of “Respiratory Device Market Size, Share & Trends Analysis Report by Diagnostic Devices (Spirometers, Sleep Test Devices, Peak Flow Meters, Pulse Oximeters, Capnographs, and Others), by Therapeutic Devices (CPAP Devices, BiPAP Devices, Humidifiers, Nebulizers, Oxygen Concentrators, Ventilators, Inhalers, and Others), and by Disposable Devices (Masks, Breathing Circuits, and Others), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/respiratory-device-market
Escalating COPD Burden Accelerates Demand for Respiratory Solutions
As per the WHO and European Respiratory Society report, 81.7 million people in the European region are living with a chronic respiratory disease (CRD), and 6.8 million are newly diagnosed each year; also, chronic obstructive pulmonary disease (COPD) accounts for 80% of CRD-related deaths in Europe. On the global upfront also WHO reported that COPD cases will rise globally by 23% between 2020 and 2050, with the steepest increases among women and in low- and middle-income countries. These rising chronic respiratory disease statistics are significantly driving the demand for respiratory devices market globally.
COPD Diagnosis and Treatment: Role of Respiratory Devices
COPD is a progressive disease which can get worse quietly without the patient noticing until it's too late. Spirometry is the definitive diagnostic tool for COPD, as many lung diseases share similar symptoms. It measures lung function using FVC (total exhaled air) and FEV1 (air exhaled in the first second). A significantly reduced FEV1 confirms airway obstruction, enabling doctors to accurately diagnose COPD and begin appropriate treatment without delay.
Apart from this, oral pills for COPD often act slowly and can cause whole-body side effects. In this scenario, inhalers and nebulizers provide targeted therapy by converting liquid medicine into a fine, breathable mist that delivers bronchodilators (to relax airway muscles) and steroids (to reduce inflammation) directly to the lungs for faster and more effective relief.
Other Respiratory Devices Categories and Demand Drivers
Recent Key Product Launches in the Global Respiratory Devices Market
Market Coverage
Key questions addressed by the report.
Global Respiratory Device Market Report Segment
By Diagnostic Devices
By Therapeutic Devices
By Disposable Devices
Global Respiratory Device Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/respiratory-device-market